Does COPANLISIB Cause Metastases to bone marrow? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Metastases to bone marrow have been filed in association with COPANLISIB. This represents 2.5% of all adverse event reports for COPANLISIB.
9
Reports of Metastases to bone marrow with COPANLISIB
2.5%
of all COPANLISIB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Metastases to bone marrow From COPANLISIB?
Of the 9 reports, 9 (100.0%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Metastases to bone marrow Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for COPANLISIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does COPANLISIB Cause?
Pyrexia (58)
Off label use (43)
Hyperglycaemia (27)
Hypertension (24)
Rash maculo-papular (24)
Pneumonia (20)
Sepsis (19)
Diarrhoea (18)
Rash (16)
Febrile neutropenia (15)
What Other Drugs Cause Metastases to bone marrow?
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (40)
CYTARABINE (36)
CARBOPLATIN (35)
ZOLEDRONIC ACID (32)
ETOPOSIDE (31)
OXALIPLATIN (30)
RIBOCICLIB (29)
RITUXIMAB (29)
VINCRISTINE (28)
Which COPANLISIB Alternatives Have Lower Metastases to bone marrow Risk?
COPANLISIB vs COPAXONE
COPANLISIB vs COPEGUS
COPANLISIB vs COPPER
COPANLISIB vs CORDARONE
COPANLISIB vs CORICIDIN HBP COLD AND FLU